Correlation Between Cannara Biotech and HLS Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and HLS Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and HLS Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannara Biotech and HLS Therapeutics, you can compare the effects of market volatilities on Cannara Biotech and HLS Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of HLS Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and HLS Therapeutics.
Diversification Opportunities for Cannara Biotech and HLS Therapeutics
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cannara and HLS is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and HLS Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HLS Therapeutics and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with HLS Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HLS Therapeutics has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and HLS Therapeutics go up and down completely randomly.
Pair Corralation between Cannara Biotech and HLS Therapeutics
Assuming the 90 days horizon Cannara Biotech is expected to generate 1.07 times more return on investment than HLS Therapeutics. However, Cannara Biotech is 1.07 times more volatile than HLS Therapeutics. It trades about 0.0 of its potential returns per unit of risk. HLS Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 81.00 in Cannara Biotech on August 30, 2024 and sell it today you would lose (30.00) from holding Cannara Biotech or give up 37.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cannara Biotech vs. HLS Therapeutics
Performance |
| Timeline |
| Cannara Biotech |
| HLS Therapeutics |
Cannara Biotech and HLS Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cannara Biotech and HLS Therapeutics
The main advantage of trading using opposite Cannara Biotech and HLS Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, HLS Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HLS Therapeutics will offset losses from the drop in HLS Therapeutics' long position.| Cannara Biotech vs. Benchmark Botanics | Cannara Biotech vs. Speakeasy Cannabis Club | Cannara Biotech vs. City View Green | Cannara Biotech vs. BC Craft Supply |
| HLS Therapeutics vs. Aion Therapeutic | HLS Therapeutics vs. Cannara Biotech | HLS Therapeutics vs. Knight Therapeutics | HLS Therapeutics vs. Canntab Therapeutics Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |